nodes	percent_of_prediction	percent_of_DWPC	metapath
Zileuton—PTGS1—malignant glioma	0.577	1	CbGaD
Zileuton—CYP1A2—Carmustine—malignant glioma	0.146	0.569	CbGbCtD
Zileuton—CYP3A4—Temozolomide—malignant glioma	0.11	0.43	CbGbCtD
Zileuton—Traumatic liver injury—Temozolomide—malignant glioma	0.00364	0.105	CcSEcCtD
Zileuton—Tiaprofenic acid—PTGS1—malignant glioma	0.00218	0.636	CrCbGaD
Zileuton—Hepatotoxicity—Carmustine—malignant glioma	0.00182	0.0523	CcSEcCtD
Zileuton—Hepatotoxicity—Temozolomide—malignant glioma	0.00176	0.0505	CcSEcCtD
Zileuton—Liver injury—Temozolomide—malignant glioma	0.00161	0.0464	CcSEcCtD
Zileuton—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00149	0.0429	CcSEcCtD
Zileuton—Neck pain—Carmustine—malignant glioma	0.00142	0.0409	CcSEcCtD
Zileuton—Vaginal inflammation—Temozolomide—malignant glioma	0.00136	0.039	CcSEcCtD
Zileuton—Vaginal infection—Temozolomide—malignant glioma	0.00128	0.0368	CcSEcCtD
Zileuton—Tiaprofenic acid—PTGS2—malignant glioma	0.00124	0.364	CrCbGaD
Zileuton—Upper respiratory tract infection—Temozolomide—malignant glioma	0.000791	0.0228	CcSEcCtD
Zileuton—Urinary tract infection—Carmustine—malignant glioma	0.000763	0.022	CcSEcCtD
Zileuton—Urinary tract infection—Temozolomide—malignant glioma	0.000737	0.0212	CcSEcCtD
Zileuton—Sinusitis—Temozolomide—malignant glioma	0.000712	0.0205	CcSEcCtD
Zileuton—Hepatitis—Temozolomide—malignant glioma	0.000681	0.0196	CcSEcCtD
Zileuton—Ill-defined disorder—Temozolomide—malignant glioma	0.00055	0.0158	CcSEcCtD
Zileuton—Malaise—Temozolomide—malignant glioma	0.000535	0.0154	CcSEcCtD
Zileuton—Chest pain—Carmustine—malignant glioma	0.000522	0.015	CcSEcCtD
Zileuton—Myalgia—Carmustine—malignant glioma	0.000522	0.015	CcSEcCtD
Zileuton—Arthralgia—Temozolomide—malignant glioma	0.000505	0.0145	CcSEcCtD
Zileuton—Myalgia—Temozolomide—malignant glioma	0.000505	0.0145	CcSEcCtD
Zileuton—Discomfort—Temozolomide—malignant glioma	0.000499	0.0143	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000456	0.0131	CcSEcCtD
Zileuton—Insomnia—Carmustine—malignant glioma	0.000453	0.013	CcSEcCtD
Zileuton—Somnolence—Carmustine—malignant glioma	0.000445	0.0128	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000441	0.0127	CcSEcCtD
Zileuton—Insomnia—Temozolomide—malignant glioma	0.000438	0.0126	CcSEcCtD
Zileuton—Gastrointestinal disorder—Carmustine—malignant glioma	0.000432	0.0124	CcSEcCtD
Zileuton—Somnolence—Temozolomide—malignant glioma	0.00043	0.0124	CcSEcCtD
Zileuton—Pain—Carmustine—malignant glioma	0.000428	0.0123	CcSEcCtD
Zileuton—Constipation—Carmustine—malignant glioma	0.000428	0.0123	CcSEcCtD
Zileuton—Dyspepsia—Temozolomide—malignant glioma	0.000426	0.0123	CcSEcCtD
Zileuton—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000418	0.012	CcSEcCtD
Zileuton—Pain—Temozolomide—malignant glioma	0.000414	0.0119	CcSEcCtD
Zileuton—Constipation—Temozolomide—malignant glioma	0.000414	0.0119	CcSEcCtD
Zileuton—Feeling abnormal—Carmustine—malignant glioma	0.000413	0.0119	CcSEcCtD
Zileuton—Feeling abnormal—Temozolomide—malignant glioma	0.000399	0.0115	CcSEcCtD
Zileuton—Body temperature increased—Carmustine—malignant glioma	0.000396	0.0114	CcSEcCtD
Zileuton—Urticaria—Temozolomide—malignant glioma	0.000384	0.0111	CcSEcCtD
Zileuton—Body temperature increased—Temozolomide—malignant glioma	0.000382	0.011	CcSEcCtD
Zileuton—Hypersensitivity—Carmustine—malignant glioma	0.000369	0.0106	CcSEcCtD
Zileuton—Hypersensitivity—Temozolomide—malignant glioma	0.000356	0.0103	CcSEcCtD
Zileuton—Diarrhoea—Carmustine—malignant glioma	0.000343	0.00986	CcSEcCtD
Zileuton—Pruritus—Temozolomide—malignant glioma	0.000342	0.00985	CcSEcCtD
Zileuton—Dizziness—Carmustine—malignant glioma	0.000331	0.00953	CcSEcCtD
Zileuton—Diarrhoea—Temozolomide—malignant glioma	0.000331	0.00953	CcSEcCtD
Zileuton—Dizziness—Temozolomide—malignant glioma	0.00032	0.00921	CcSEcCtD
Zileuton—Vomiting—Carmustine—malignant glioma	0.000318	0.00916	CcSEcCtD
Zileuton—Rash—Carmustine—malignant glioma	0.000316	0.00908	CcSEcCtD
Zileuton—Dermatitis—Carmustine—malignant glioma	0.000315	0.00908	CcSEcCtD
Zileuton—Headache—Carmustine—malignant glioma	0.000314	0.00903	CcSEcCtD
Zileuton—Vomiting—Temozolomide—malignant glioma	0.000308	0.00885	CcSEcCtD
Zileuton—Rash—Temozolomide—malignant glioma	0.000305	0.00878	CcSEcCtD
Zileuton—Dermatitis—Temozolomide—malignant glioma	0.000305	0.00877	CcSEcCtD
Zileuton—Headache—Temozolomide—malignant glioma	0.000303	0.00872	CcSEcCtD
Zileuton—Nausea—Carmustine—malignant glioma	0.000297	0.00856	CcSEcCtD
Zileuton—Nausea—Temozolomide—malignant glioma	0.000287	0.00827	CcSEcCtD
Zileuton—CYP2C9—Biological oxidations—GSTP1—malignant glioma	6.27e-05	0.000487	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—PIK3CB—malignant glioma	6.26e-05	0.000486	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PDGFRA—malignant glioma	6.22e-05	0.000483	CbGpPWpGaD
Zileuton—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	6.18e-05	0.00048	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.05e-05	0.00047	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—SPP1—malignant glioma	6.04e-05	0.000469	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CXCL8—malignant glioma	6.01e-05	0.000467	CbGpPWpGaD
Zileuton—CYP3A4—Biological oxidations—GSTT1—malignant glioma	5.96e-05	0.000463	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—BCHE—malignant glioma	5.91e-05	0.000459	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—ASMT—malignant glioma	5.89e-05	0.000458	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—SLC5A5—malignant glioma	5.84e-05	0.000454	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	5.78e-05	0.000449	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PIK3CG—malignant glioma	5.77e-05	0.000448	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	5.75e-05	0.000447	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—IL2—malignant glioma	5.75e-05	0.000447	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—TERT—malignant glioma	5.72e-05	0.000445	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	5.65e-05	0.000439	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	5.65e-05	0.000439	CbGpPWpGaD
Zileuton—CYP3A4—Biological oxidations—PTGS1—malignant glioma	5.59e-05	0.000434	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PDGFB—malignant glioma	5.59e-05	0.000434	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PPARG—malignant glioma	5.57e-05	0.000433	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—FGFR1—malignant glioma	5.56e-05	0.000432	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—BCAN—malignant glioma	5.54e-05	0.00043	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	5.52e-05	0.000429	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—HIF1A—malignant glioma	5.48e-05	0.000425	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—IDH2—malignant glioma	5.47e-05	0.000425	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	5.47e-05	0.000425	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—RTEL1—malignant glioma	5.42e-05	0.000421	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	5.38e-05	0.000418	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	5.38e-05	0.000418	CbGpPWpGaD
Zileuton—CYP1A2—Biological oxidations—GSTP1—malignant glioma	5.36e-05	0.000416	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	5.34e-05	0.000415	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CAV1—malignant glioma	5.3e-05	0.000412	CbGpPWpGaD
Zileuton—CYP1A2—Metapathway biotransformation—GSTP1—malignant glioma	5.28e-05	0.000411	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—KDR—malignant glioma	5.24e-05	0.000407	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	5.16e-05	0.000401	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—CYP2B6—malignant glioma	5.15e-05	0.0004	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PIK3CD—malignant glioma	5.07e-05	0.000394	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—FN1—malignant glioma	5.04e-05	0.000392	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—F2—malignant glioma	5.04e-05	0.000392	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—BAD—malignant glioma	4.98e-05	0.000387	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—NOTCH1—malignant glioma	4.93e-05	0.000383	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CD80—malignant glioma	4.83e-05	0.000376	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—APC—malignant glioma	4.82e-05	0.000375	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PIK3CG—malignant glioma	4.82e-05	0.000375	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4.77e-05	0.000371	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—EGF—malignant glioma	4.77e-05	0.000371	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PTPN11—malignant glioma	4.74e-05	0.000368	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—IDH1—malignant glioma	4.71e-05	0.000366	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—GSTP1—malignant glioma	4.7e-05	0.000365	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—CAT—malignant glioma	4.58e-05	0.000356	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—SPHK1—malignant glioma	4.55e-05	0.000354	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—BRAF—malignant glioma	4.53e-05	0.000352	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	4.53e-05	0.000352	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—IDH2—malignant glioma	4.46e-05	0.000347	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—CYP2C18—malignant glioma	4.46e-05	0.000347	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PIK3CB—malignant glioma	4.42e-05	0.000343	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—AKT2—malignant glioma	4.41e-05	0.000343	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—EGFR—malignant glioma	4.39e-05	0.000342	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	4.38e-05	0.000341	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PTGS2—malignant glioma	4.38e-05	0.00034	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—NCOR1—malignant glioma	4.32e-05	0.000336	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PIK3CD—malignant glioma	4.24e-05	0.00033	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	4.21e-05	0.000327	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	4.21e-05	0.000327	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—PIK3CA—malignant glioma	4.2e-05	0.000326	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—CYP2B6—malignant glioma	4.2e-05	0.000326	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—RTEL1—malignant glioma	4.18e-05	0.000325	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—KRAS—malignant glioma	4.15e-05	0.000323	CbGpPWpGaD
Zileuton—CYP3A4—Biological oxidations—GSTP1—malignant glioma	4.13e-05	0.000321	CbGpPWpGaD
Zileuton—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	4.08e-05	0.000317	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—FGF2—malignant glioma	4.06e-05	0.000316	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	3.87e-05	0.000301	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—IDH1—malignant glioma	3.84e-05	0.000298	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.83e-05	0.000298	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PTEN—malignant glioma	3.82e-05	0.000297	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—PIK3CA—malignant glioma	3.81e-05	0.000296	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—MDM2—malignant glioma	3.8e-05	0.000295	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—RAF1—malignant glioma	3.79e-05	0.000294	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—ERBB2—malignant glioma	3.75e-05	0.000291	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	3.75e-05	0.000291	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—SPHK1—malignant glioma	3.71e-05	0.000289	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.7e-05	0.000287	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PIK3CB—malignant glioma	3.7e-05	0.000287	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—COX8A—malignant glioma	3.64e-05	0.000283	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—CYP2C18—malignant glioma	3.64e-05	0.000283	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—GSTT1—malignant glioma	3.61e-05	0.00028	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CXCL8—malignant glioma	3.55e-05	0.000276	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—CAV1—malignant glioma	3.52e-05	0.000274	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—AKT1—malignant glioma	3.43e-05	0.000267	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.43e-05	0.000267	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CASP3—malignant glioma	3.4e-05	0.000264	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—IL2—malignant glioma	3.39e-05	0.000264	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PTGS1—malignant glioma	3.38e-05	0.000263	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.37e-05	0.000262	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.37e-05	0.000262	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	3.25e-05	0.000253	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—MMP9—malignant glioma	3.21e-05	0.00025	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PIK3CG—malignant glioma	3.21e-05	0.000249	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PTEN—malignant glioma	3.19e-05	0.000248	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—BCHE—malignant glioma	3.14e-05	0.000244	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.12e-05	0.000243	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—AKT1—malignant glioma	3.12e-05	0.000242	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—COX8A—malignant glioma	3.11e-05	0.000242	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—SLC5A5—malignant glioma	3.11e-05	0.000241	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PPARG—malignant glioma	3.1e-05	0.000241	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ASMT—malignant glioma	3.1e-05	0.000241	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	3.03e-05	0.000235	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.02e-05	0.000234	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—GSTT1—malignant glioma	2.94e-05	0.000229	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.94e-05	0.000228	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—BCAN—malignant glioma	2.91e-05	0.000226	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.91e-05	0.000226	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—VEGFA—malignant glioma	2.88e-05	0.000224	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—STAT3—malignant glioma	2.86e-05	0.000222	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PIK3CD—malignant glioma	2.82e-05	0.000219	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	2.78e-05	0.000216	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.75e-05	0.000213	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PIK3CA—malignant glioma	2.69e-05	0.000209	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—MYC—malignant glioma	2.65e-05	0.000206	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ASMT—malignant glioma	2.64e-05	0.000206	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—EGFR—malignant glioma	2.6e-05	0.000202	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	2.59e-05	0.000201	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—BCHE—malignant glioma	2.56e-05	0.000199	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.54e-05	0.000197	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—SLC5A5—malignant glioma	2.53e-05	0.000197	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—GSTP1—malignant glioma	2.5e-05	0.000194	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—BCAN—malignant glioma	2.49e-05	0.000193	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PIK3CB—malignant glioma	2.46e-05	0.000191	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—KRAS—malignant glioma	2.45e-05	0.000191	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PTGS2—malignant glioma	2.44e-05	0.000189	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—CAT—malignant glioma	2.43e-05	0.000189	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—COX8A—malignant glioma	2.4e-05	0.000187	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.39e-05	0.000186	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.37e-05	0.000184	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—IDH2—malignant glioma	2.35e-05	0.000182	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—NCOR1—malignant glioma	2.3e-05	0.000179	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PIK3CA—malignant glioma	2.25e-05	0.000175	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.21e-05	0.000172	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CYP2B6—malignant glioma	2.21e-05	0.000171	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—AKT1—malignant glioma	2.2e-05	0.000171	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—TP53—malignant glioma	2.18e-05	0.000169	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PTEN—malignant glioma	2.12e-05	0.000165	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.07e-05	0.000161	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ASMT—malignant glioma	2.04e-05	0.000159	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—GSTP1—malignant glioma	2.04e-05	0.000158	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—IDH1—malignant glioma	2.02e-05	0.000157	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—IDH2—malignant glioma	2e-05	0.000156	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—CAT—malignant glioma	1.98e-05	0.000154	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—SPHK1—malignant glioma	1.95e-05	0.000152	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—BCAN—malignant glioma	1.92e-05	0.000149	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CYP2C18—malignant glioma	1.91e-05	0.000149	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.89e-05	0.000147	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CYP2B6—malignant glioma	1.88e-05	0.000146	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—NCOR1—malignant glioma	1.87e-05	0.000146	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—CAV1—malignant glioma	1.87e-05	0.000146	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—AKT1—malignant glioma	1.84e-05	0.000143	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.8e-05	0.00014	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.79e-05	0.000139	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—IDH1—malignant glioma	1.72e-05	0.000134	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PIK3CG—malignant glioma	1.71e-05	0.000133	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—SPHK1—malignant glioma	1.67e-05	0.00013	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PPARG—malignant glioma	1.65e-05	0.000128	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.64e-05	0.000128	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CYP2C18—malignant glioma	1.63e-05	0.000127	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.59e-05	0.000123	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—IDH2—malignant glioma	1.55e-05	0.00012	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GSTT1—malignant glioma	1.55e-05	0.00012	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.54e-05	0.00012	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—CAV1—malignant glioma	1.53e-05	0.000119	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PIK3CD—malignant glioma	1.5e-05	0.000117	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PIK3CA—malignant glioma	1.5e-05	0.000116	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.46e-05	0.000113	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.45e-05	0.000113	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PTGS1—malignant glioma	1.45e-05	0.000113	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.44e-05	0.000112	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.4e-05	0.000109	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PIK3CG—malignant glioma	1.39e-05	0.000108	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.35e-05	0.000105	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—BCHE—malignant glioma	1.35e-05	0.000105	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PPARG—malignant glioma	1.34e-05	0.000104	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—SLC5A5—malignant glioma	1.33e-05	0.000103	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—IDH1—malignant glioma	1.33e-05	0.000103	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GSTT1—malignant glioma	1.32e-05	0.000103	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PIK3CB—malignant glioma	1.31e-05	0.000102	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PTGS2—malignant glioma	1.3e-05	0.000101	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—SPHK1—malignant glioma	1.29e-05	0.0001	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.26e-05	9.8e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.26e-05	9.78e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.25e-05	9.69e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PTGS1—malignant glioma	1.24e-05	9.62e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.23e-05	9.59e-05	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—AKT1—malignant glioma	1.22e-05	9.52e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PIK3CD—malignant glioma	1.22e-05	9.51e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—BCHE—malignant glioma	1.15e-05	8.95e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—SLC5A5—malignant glioma	1.14e-05	8.84e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PTEN—malignant glioma	1.13e-05	8.78e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.09e-05	8.45e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.08e-05	8.36e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GSTP1—malignant glioma	1.07e-05	8.33e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PIK3CB—malignant glioma	1.07e-05	8.28e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.07e-05	8.28e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PTGS2—malignant glioma	1.06e-05	8.21e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CAT—malignant glioma	1.04e-05	8.11e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GSTT1—malignant glioma	1.02e-05	7.93e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—NCOR1—malignant glioma	9.85e-06	7.65e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PTGS1—malignant glioma	9.56e-06	7.43e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	9.29e-06	7.22e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PTEN—malignant glioma	9.21e-06	7.16e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GSTP1—malignant glioma	9.16e-06	7.12e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CAT—malignant glioma	8.91e-06	6.93e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—BCHE—malignant glioma	8.89e-06	6.9e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—SLC5A5—malignant glioma	8.78e-06	6.82e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—NCOR1—malignant glioma	8.42e-06	6.54e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CAV1—malignant glioma	8.03e-06	6.24e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PIK3CA—malignant glioma	7.97e-06	6.2e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.67e-06	5.96e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PIK3CG—malignant glioma	7.31e-06	5.68e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GSTP1—malignant glioma	7.07e-06	5.49e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PPARG—malignant glioma	7.06e-06	5.49e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CAT—malignant glioma	6.88e-06	5.35e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CAV1—malignant glioma	6.86e-06	5.33e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.56e-06	5.09e-05	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—AKT1—malignant glioma	6.51e-06	5.06e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PIK3CA—malignant glioma	6.5e-06	5.05e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—NCOR1—malignant glioma	6.5e-06	5.05e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PIK3CD—malignant glioma	6.43e-06	5e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PIK3CG—malignant glioma	6.25e-06	4.86e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PPARG—malignant glioma	6.03e-06	4.69e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PIK3CB—malignant glioma	5.6e-06	4.36e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PTGS2—malignant glioma	5.55e-06	4.32e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PIK3CD—malignant glioma	5.49e-06	4.27e-05	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—AKT1—malignant glioma	5.31e-06	4.13e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CAV1—malignant glioma	5.3e-06	4.12e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PTEN—malignant glioma	4.84e-06	3.76e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PIK3CG—malignant glioma	4.82e-06	3.75e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PIK3CB—malignant glioma	4.79e-06	3.72e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PTGS2—malignant glioma	4.75e-06	3.69e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PPARG—malignant glioma	4.66e-06	3.62e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PIK3CD—malignant glioma	4.24e-06	3.3e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PTEN—malignant glioma	4.14e-06	3.22e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PIK3CB—malignant glioma	3.7e-06	2.87e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PTGS2—malignant glioma	3.66e-06	2.85e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PIK3CA—malignant glioma	3.42e-06	2.66e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PTEN—malignant glioma	3.19e-06	2.48e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PIK3CA—malignant glioma	2.92e-06	2.27e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—AKT1—malignant glioma	2.79e-06	2.17e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—AKT1—malignant glioma	2.39e-06	1.85e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PIK3CA—malignant glioma	2.25e-06	1.75e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—AKT1—malignant glioma	1.84e-06	1.43e-05	CbGpPWpGaD
